Drug Infusion System Market Size, Share & Trends Analysis Report By Product Type (Elastomeric infusion system, Disposable infusion system, Syringe infusion system, Peristaltic pump, Multi-channel pump, Patient-controlled analgesia (PCA) pump, Insulin pump, Implantable infusion system), By Application (Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Others), By Mode of Administration (Intravenous, Subcutaneous, Arterial, Epidural, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Drug Infusion System Market Size

The global drug infusion system market size was valued at USD 10.23 billion in 2025 and is projected to grow from USD 11.16 billion in 2026 to USD 22.40 billion by 2034, registering a CAGR of 9.1% during the forecast period from 2026 to 2034. North America dominated the drug infusion system market with a market share of 38.4% in 2025.

A drug infusion system is a medical device used to administer fluids, drugs, and therapeutic substances directly into a patient's bloodstream in a controlled and regulated manner. These systems are widely employed in various healthcare settings, such as hospitals, clinics, ambulatory care, and home healthcare. Drug infusion systems are critical in delivering medications and therapies such as chemotherapy, pain management, insulin administration, and antibiotic administration, among others.

The drug infusion system market share is expected to increase during the forecast period due to factors such as increasing prevalence of chronic diseases such as cardiovascular disease, strokes, cancer, type 2 diabetes, and so on, growing geriatric population, technological advancements, rising healthcare expenditure, portability and ease of use, and visual monitoring features. Nonetheless, the high cost of drug infusion systems, a scarcity of experienced professionals, and stringent government regulations are projected to impede market expansion throughout the projection period.

Product Type Insights

The market is further segmented into Elastomeric infusion systems, disposable infusion systems, syringe infusion systems, peristaltic pumps, multi-channel pumps, patient-controlled analgesia (PCA) pumps, insulin pumps, and implantable infusion systems. Disposable Infusion Systems occupied the maximum share of the market. Disposable infusion systems are single-use devices that give drugs, fluids, or nutrients intravenously. To avoid cross-contamination, these systems are discarded after a single usage. In hospitals, disposable infusion systems are routinely used for hydration, medicine administration, and blood transfusions.

Elastomeric infusion systems are disposable, portable devices that give medication at a set rate for a set amount of time. They rely on the flexibility of a balloon-like reservoir to gently infuse the drug.

Request Customizationto receive a tailored report.

Application Insights

The segment can be bifurcated by application into Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, and Pediatrics. Oncology/Chemotherapy holds the largest share in the market. In oncology and chemotherapy, drug infusion systems are widely utilized to administer anticancer drugs. These technologies ensure that chemotherapy medications are delivered precisely and controllably to cancer patients. Oncology infusion systems are essential for administering chemotherapeutic drugs, targeted treatments, and immunotherapies to cancer patients.

Infusion devices are important in diabetes management by delivering insulin to diabetic patients. Insulin pumps are a prominent infusion system that keeps blood glucose levels within normal limits.

Mode of Administration Insights

The market is sub-segmented into Intravenous, Subcutaneous, Arterial, and Epidural. Intravenous is the major Mode of administration in the market. Intravenous drug infusion is the administration of drugs or fluids directly into a patient's bloodstream via a vein. Many drugs are administered via IV infusion, which allows rapid and exact drug delivery. The injection of pharmaceuticals or fluids into the fatty tissue layer just beneath the skin is known as subcutaneous drug infusion. Subcutaneous infusion is often slower than IV infusion and is appropriate for drugs that can be absorbed through the skin.

End Users Insights

The market is classified into Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers based on end-users. Hospitals led the market growth. Hospitals are the main healthcare facilities that offer a wide range of medical services, such as acute care, surgery, and specialist therapies. Drug infusion systems are widely used in hospitals for various medical operations and patient care. In hospitals, drug infusion systems are used for chemotherapy, surgical care, intensive care, normal ward care, and various medical illnesses requiring medicine or fluid administration.

Ambulatory Surgical Centers (ASCs), often known as outpatient surgery centers, are medical institutions that specialize in delivering outpatient surgical and procedural treatments to patients. These facilities perform surgeries and medical procedures that do not necessitate an overnight stay in the hospital.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global drug infusion system market shareholder and is estimated to grow at a CAGR of % over the forecast period due to the region's increasing prevalence of chronic diseases. The region's increased prevalence of chronic diseases such as cancer, diabetes, and cardiovascular problems is a major reason driving the strong demand for drug infusion systems to dispense drugs appropriately. The aging population in North America is the second reason driving market revenue growth, as older people frequently require specialized care and long-term drug delivery, necessitating infusion pumps and systems. According to the Heart Disease and Stroke Statistics 2018, cardiovascular disease was responsible for 836,546 deaths in the United States. The significant prevalence of cardiovascular disorders in this region fuels market expansion.

Furthermore, the development of smart pumps and integrated technologies that improve patient safety and treatment outcomes, together with the region's continued focus on technical breakthroughs and advances in healthcare, is driving market revenue growth in this region. Furthermore, as these companies debut new products and enhance their market share, the country's established healthcare infrastructure and the existence of big industry competitors are boosting market revenue growth in this region.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Drug Infusion System Market Trends

Europe is expected to expand significantly during the forecast period. The rising prevalence of chronic disease, rising healthcare expenditure, and rising healthcare activities are driving the expansion of this market in Europe. According to the Organization for Economic Cooperation and Development (OECD), chronic disease killed 550,000 working-age persons in European Union countries in 2016. The market is likely to grow because of this region's high frequency of chronic disease. Furthermore, the goal of healthcare practitioners to improve patient safety and treatment outcomes is driving market revenue growth in Europe through a focus on technological upgrades and the development of novel infusion devices. Finally, as these companies debut new products and enhance their market share in Europe, the region's developed healthcare system and the existence of large market competitors are boosting market revenue growth.

Asia Pacific Drug Infusion System Market Trends

Asia-Pacific was predicted to be the fastest-expanding region for the drug infusion system market. Infusion devices are widely utilized to inject insulin into patients' bodies. Diabetes's rising prevalence has an impact on the market in this region. According to the Asian Diabetes Prevention Initiative, Asia has 60% of the world's diabetes population. The rapid urbanization and developing healthcare infrastructure in various APAC nations drive the demand for novel medical devices, particularly medication infusion systems. Second, the prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders is rising, driving market revenue growth. These illnesses necessitate precise and effective drug administration via infusion pumps and systems. This drives the expansion of the market in this region.

The Middle East and Africa have the smallest proportion of the worldwide Drug infusion system market because of strict government laws and underdeveloped economies. However, this region's increased investment by private market players can promote market growth.

List of Key and Emerging Players in Drug Infusion System Market